Vaccitech (VACC) News Today → Trump’s Former Wingman Bets Big on AI (From Banyan Hill Publishing) (Ad) Free VACC Stock Alerts $2.32 -0.03 (-1.28%) (As of 05/14/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 2:08 AM | americanbankingnews.comVaccitech (NASDAQ:VACC) Stock Price Up 0.4%April 30, 2024 | msn.comWhat is AstraZeneca Vaccine? Know the Recently Discovered Side Effects of the COVID-19 AntibodyApril 19, 2024 | markets.businessinsider.comBuy Rating on Barinthus Biotherapeutics Backed by Promising Clinical Trials and Strong Valuation ProspectsApril 6, 2024 | msn.comLondon is a bad place to raise money, says life sciences tsar Sir John BellMarch 2, 2024 | seekingalpha.comArbutus Biopharma Corporation (ABUS) Q4 2023 Earnings Call TranscriptJanuary 8, 2024 | markets.businessinsider.comPositive Clinical Outlook and Strong Capital Position Justify Buy Rating for Barinthus BiotherapeuticsJanuary 8, 2024 | finanznachrichten.deBarinthus Biotherapeutics: Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate MilestonesJanuary 5, 2024 | finance.yahoo.comBarinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate MilestonesDecember 22, 2023 | markets.businessinsider.comBuy Rating for Barinthus Biotherapeutics: Promising Pipeline and Strategic Partnerships Signal Investment OpportunityDecember 21, 2023 | markets.businessinsider.comBarinthus Biotherapeutics Collaborates With CEPI And University Of Oxford For New MERS VaccineDecember 21, 2023 | finance.yahoo.comNew partnership aims to advance vaccine against MERS coronavirusDecember 13, 2023 | finance.yahoo.comInfluenza Vaccine Market to grow by USD 2.93 billion from 2022 to 2027; North America to account for 54% of market growth - TechnavioNovember 28, 2023 | markets.businessinsider.comAnalysts’ Top Healthcare Picks: Barinthus Biotherapeutics (BRNS), Anavex Life Sciences (AVXL)November 15, 2023 | finance.yahoo.comBarinthus Biotherapeutics plc (BRNS)November 9, 2023 | finance.yahoo.comBarinthus Bio Reports Third Quarter 2023 Financial Results and Recent Corporate DevelopmentsNovember 8, 2023 | money.usnews.comBarinthus Biotherapeutics Plc. - ADRNovember 7, 2023 | msn.comBarinthus stock falls 18%, day after changing name from VaccitechNovember 6, 2023 | msn.comVaccitech rebrands as Barinthus, plans to present data at AASLD meetingNovember 6, 2023 | finance.yahoo.comVaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution into a T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, and CancerSeptember 28, 2023 | seekingalpha.comSIRI, EC and PBTS among pre-market losersSeptember 26, 2023 | 247wallst.comMorgan Stanley Downgrades VaccitechSeptember 26, 2023 | uk.finance.yahoo.comInnovative Therapeutic Cancer Vaccines Drive Unprecedented Growth in Global Cancer Vaccines Market to 2028September 26, 2023 | seekingalpha.comVaccitech surges despite Morgan Stanley downgradeSeptember 26, 2023 | finance.yahoo.comVaccitech plc (NASDAQ:VACC) surges 85%; individual investors who own 44% shares profited along with institutionsSeptember 25, 2023 | benzinga.comGlobal Cancer Vaccines Market to Skyrocket, Projected to Reach $12.1 Billion by 2028September 25, 2023 | marketwatch.comHealth Care Up on Defensive Bets -- Health Care RoundupSeptember 25, 2023 | msn.comMorgan Stanley Downgrades Vaccitech plc - ADR (VACC)September 25, 2023 | marketwatch.comVaccitech Shares Surge as Alliance Global Initiates CoverageSeptember 25, 2023 | marketbeat.comTrading was temporarily halted for "VACC" at 12:09 PM with a stated reason of "LULD pause."September 13, 2023 | finance.yahoo.comVaccitech to Host KOL Webinar on Seeking a Functional Cure for Chronic Hepatitis B on September 20, 2023September 12, 2023 | bizjournals.comArbutus BioPharma narrows research focus to extend cash runwayAugust 10, 2023 | finanznachrichten.deVaccitech plc: Vaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate DevelopmentsAugust 10, 2023 | finance.yahoo.comVaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate DevelopmentsAugust 9, 2023 | finance.yahoo.comVaccitech (NASDAQ:VACC) shareholders have endured a 50% loss from investing in the stock a year agoJune 22, 2023 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Vaccitech Plc (VACC) and Aeglea Biotherapeutics (AGLE)June 13, 2023 | markets.businessinsider.comAnalyst Expectations for Vaccitech's FutureJune 12, 2023 | finance.yahoo.comVaccitech Doses First Patient in PCA001, a Prostate Cancer Phase 1/2 Clinical Trial of VTP-850 Immunotherapeutic Candidate in Men with Rising PSA after Definitive Local TherapyMay 19, 2023 | finance.yahoo.comNewsflash: Vaccitech plc (NASDAQ:VACC) Analysts Have Been Trimming Their Revenue ForecastsMay 17, 2023 | markets.businessinsider.comAnalysts’ Top Healthcare Picks: Arcus Biosciences (RCUS), Vaccitech Plc (VACC)May 16, 2023 | msn.comMorgan Stanley Maintains Vaccitech plc - ADR (VACC) Overweight RecommendationMay 12, 2023 | msn.comVaccitech: Q1 Earnings InsightsMay 12, 2023 | finance.yahoo.comVaccitech Reports First Quarter 2023 Financial Results and Recent Corporate DevelopmentsMay 5, 2023 | finance.yahoo.comRevenues Working Against Vaccitech plc's (NASDAQ:VACC) Share PriceApril 17, 2023 | finance.yahoo.comVaccitech Presents Interim Data from Phase 1b/2 Study of VTP-200 at 35th Annual International Papillomavirus Conference (IPVC) Highlighting Favorable Tolerability and Immunogenicity ProfileMarch 30, 2023 | marketwatch.comGlobal Influenza Vaccines Market Size 2023 to 2026 Size and Share Survey ReportMarch 29, 2023 | markets.businessinsider.comVaccitech Plc (VACC) Gets a Buy from Morgan StanleyMarch 29, 2023 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Kodiak Sciences (KOD) and Vaccitech Plc (VACC)March 28, 2023 | finanznachrichten.deVaccitech plc: Vaccitech Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis BMarch 28, 2023 | finance.yahoo.comVaccitech Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis BMarch 27, 2023 | msn.comVaccitech Earnings Perspective: Return On Capital Employed Get Vaccitech News Delivered to You Automatically Sign up to receive the latest news and ratings for VACC and its competitors with MarketBeat's FREE daily newsletter. Email Address Bill Clinton Backing Biden Replacement??? (Ad)Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August… Click here now for my urgent election forecast. VACC Media Mentions By Week VACC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VACC News Sentiment▼-0.300.55▲Average Medical News Sentiment VACC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VACC Articles This Week▼10▲VACC Articles Average Week Get Vaccitech News Delivered to You Automatically Sign up to receive the latest news and ratings for VACC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Chimerix News Today LifeVantage News Today Oncolytics Biotech News Today Barinthus Biotherapeutics News Today Milestone Pharmaceuticals News Today Annovis Bio News Today ProPhase Labs News Today YS Biopharma News Today Spero Therapeutics News Today Eton Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VACC) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport Societyis this a buy and hold stock?Tips4TradersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldTop 5 Tech Stocks to Buy for 2024Daily Market AlertsTop 5 AI Stocks to Buy for 2024Market Moving TrendsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccitech plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.